DOI QR코드

DOI QR Code

Visceral Leishmaniasis in Rural Areas of Alborz Province of Iran and Implication to Health Policy

  • Heidari, Aliehsan (Department of Parasitology, School of Medicine, Alborz University of Medical Sciences) ;
  • Mohebali, Mehdi (Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences) ;
  • Kabir, Kourosh (SDH Reseach Center, Alborz University of Medical Sciences) ;
  • Barati, Hojatallah (Center of Against Infectious Diseases, Health Depatment, Alborz University of Medical Sciences) ;
  • Soultani, Yousef (Department of Parasitology, School of Medicine, Alborz University of Medical Sciences) ;
  • Keshavarz, Hossein (Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences) ;
  • Akhoundi, Behnaz (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Hajjaran, Homa (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences) ;
  • Reisi, Hosein (Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences)
  • 투고 : 2015.01.21
  • 심사 : 2015.07.02
  • 발행 : 2015.08.31

초록

Visceral leishmaniasis (VL) or kala-azar mainly affects children in endemic areas. This study was conducted to determine the seroprevalence of VL using direct agglutination test (DAT) in children living in rural districts of Alborz Province located 30 km from Tehran capital city of Iran. Multi-stage cluster random sampling was applied. Blood samples were randomly collected from 1,007 children under 10 years of age in the clusters. A total of 37 (3.7%) of the studied population showed anti-Leishmania infantum antibodies with titers of ${\geq}1:800$. There was a significant association between positive sera and various parts of the rural areas of Alborz Province (P<0.002). Two children with anti-Leishmania infantum antibodies titers of ${\geq}1:3,200$ indicated kala-azar clinical features and treated with anti-leishmaniasis drugs in pediatric hospital. The findings of this study indicated that Leishmania infection is prevalent in rural areas of Alborz Province. Therefore, it is necessary to increase the awareness and alertness among physicians and public health managers, particularly in high-risk rural areas of the province in Iran.

키워드

참고문헌

  1. World Health Organization. Control of leishmaniases. Technical Report Series 949. WHO Expert Committee. Geneva, Switzerland. WHO. 2010.
  2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7: e35671. https://doi.org/10.1371/journal.pone.0035671
  3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010; 36 (suppl 1): S62-S65. https://doi.org/10.1016/j.ijantimicag.2010.06.023
  4. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 2013; 8: 348-358.
  5. Mohebali M, Edrissian GH, Shirzadi MR, Akhoundi B, Hajjaran H, Zarei Z, Molaei S, Sharifi I, Mamishi S, Mahmoudvand H, Torabi V, Moshfe A, Malmasi A, Motazedian MH, Fakhar M. An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy. Travel Med Infect Dis. 2011; 9: 67-74. https://doi.org/10.1016/j.tmaid.2011.02.003
  6. Bahrami A, Rassi Y, Maleki N, Oshaghi MA, Mohebali M, Yagoobi-Ershadi MR, Rafizadeh S. Leishmania infantum DNA detection in Phlebotomus tobbi in a new northern focus of visceral leishmaniasis in Iran. Asian Pac J Trop Dis 2014; 4: 110-114. https://doi.org/10.1016/S2222-1808(14)60325-X
  7. Tofighi Naeem A, Mahmoudi S, Saboui F, Hajjaran H, Pourakbari B, Mohebali M, Zarkesh MR, Mamishi S. Clinical features and laboratory findings of visceral leishmaniasis in children referred to Children Medical Center hospital, Tehran, Iran during 2004-2011. Iran J Parasitol 2014; 9: 1-5.
  8. Bokaie S, Sharifi L, Mamishi S, Nadim A. A case series study on clinical and epidemiologic aspects of Kala Azar in patients referred to the Children's Medical Center since 1991 to 2003. Iran J Epidemiol 2006; 1(3-4): 21-26 (in Iranian).
  9. Mohebali M, Edrissian Gh H, Nadim A, Hajjaran H, Akhoundi B, Hooshmand B, Zarei Z, Arshi SH, Mirsamadi N, Manouchehri Naeini K, Mamishi S, Sanati AA, Moshfe AA, Charehdar S, Fakhar M. Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in Iran. Iran J Parasitol 2006; 1: 15-25.
  10. Harith A, Kolk AH, Leeuwenburg J, Muigai R, Huigen E, Jelsma T, Kager PM. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol 1988; 26: 1321-1325.
  11. Boelaert M, Safi S, Jacquet D, Muynck A, Van der Stuyft P, Le Ray D. Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 1999; 60: 129-134. https://doi.org/10.4269/ajtmh.1999.60.129
  12. Iranian Amar Center (available: http//:www.amar.org.ir in 2014).
  13. Mohebali M , Hajjaran H , Hamzavi Y , Mobedi I , Arshi S , Zarei Z , Akhoundi B, Naeini KM, Avizeh R, Fakhar M. Epidemiological aspects of canine visceral leishmaniasis in the Islamic Republic of Iran. Vet Parasitol 2005; 129: 243-251. https://doi.org/10.1016/j.vetpar.2005.01.010
  14. Silva ES, Schoone GJ, Gontijo CMF, Brazil RP, Pacheco RS, Schallig DF. Application of direct agglutination test (DAT) and fast agglutination screening test (FAST) for sero-diagnosis of visceral leishmaniasis in endemic area of Minas Gerais, Brazil. Kinetoplastid Biol Dis 2005; 4: 4. https://doi.org/10.1186/1475-9292-4-4
  15. Mahmoudvand H., Mohebali M, Sharifi I, Keshavarz H, Hajjaran H, Akhoundi B, Jahanbakhsh S, Zarean M, Javadi A. Epidemiological aspects of visceral leishmaniasis in Baft district, Kerman Province, Southeast of Iran. Iran J Parasitol 2011; 6: 1-11.
  16. Torabi V, Mohebali M, Edrissian Gh H, Keshavarz H, Mohajeri M, Hajjaran H, Akhoundi B, Sanati AA, Zarei Z, Delshad A. Seroepidemiological survey of visceral leishmaniasis by direct agglutination test in Bojnoord District, north Khorasan Province in 2007. Iran J Epidemiol 2009; 4: 43-50 (in Iranian).
  17. Mahami M, Mohebali M, Keshavarz H, Hajaran H, Akhoondi B, Zarei Z, Charedar S. Seroepidemiological survey of visceral leishmaniasis (Kala-azar) in Germi district, Ardabil Province. J School Public Health Inst Public Health Res 2006; 4: 45-55.
  18. Sarkari B, Pedram N, Mohebali M, Moshfe AA, Zargar MA, Akhoundi B, Shirzadi MR. Seroepidemiological study of visceral leishmaniasis in Booyerahmad district, south-west Islamic Republic of Iran. East Mediterr Health J 2010; 16: 1133-1136. https://doi.org/10.26719/2010.16.11.1133
  19. Hamzavi Y, Hamzeh B, Mohebali M. Human visceral leishmaniasis in Kermanshah province, western Iran, during 2011-2012. Iran J Parasitol 2012; 7: 49-56.
  20. Gidwani K, Kumar R, Rai M, Sundar S. Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Am J Trop Med Hyg 2009; 80: 345-346.
  21. Sakru N, Korkmaz M, Ozbel Y, Ertabaklar H, Sengul M, Toz SO. Investigation of asymptomatic visceral leishmaniasis cases using western blot in an endemic area in Turkey. New Microbiol 2007; 30: 13-18.
  22. Sisko-Kraljević K, Jeroncic A, Mohar B, Punda-Polic V. Asymptomatic Leishmania infantum infections in humans living in endemic and non-endemic areas of Croatia, 2007 to 2009. Euro Surveill 2013; 18: 20533. https://doi.org/10.2807/1560-7917.ES2013.18.29.20533
  23. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson WD Jr. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986; 154: 639-649. https://doi.org/10.1093/infdis/154.4.639
  24. Adel A, Boughoufalah A, Saegerman C, De Deken R, Bouchene Z, Soukehal A, Berkvens D, Boelaert M. Epidemiology of visceral leishmaniasis in Algeria: an update. PLoS One 2014; 9: e99207. https://doi.org/10.1371/journal.pone.0099207
  25. Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol 2014; 6: 147-154.
  26. Tanir G, Taylan Ozkan A, Daglar E. Pediatric visceral leishmaniasis in Turkey. Pediatr Int 2006; 48: 66-69. https://doi.org/10.1111/j.1442-200X.2006.02153.x
  27. Haddadzade HR, Fattahi R, Mohebali M, Akhoundi B, Ebrahimzade E. Seroepedimiological investigation of visceral lesihmaniasis in stray and owned dogs in Alborz province, Central Iran using direct agglutination test. Iran J Parasitol 2013; 8: 152-157.

피인용 문헌

  1. Autoantibodies in a Three-Year-Old Girl with Visceral Leishmaniasis: A Potential Diagnostic Pitfall vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/2081616
  2. Development of monoclonal antibodies against axenic amastigotes of Leishmania infantum strain in Iran: implication for diagnosis of Kala-azar vol.21, pp.4, 2015, https://doi.org/10.22038/ijbms.2018.25355.6264
  3. Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran vol.117, pp.11, 2015, https://doi.org/10.1007/s00436-018-6041-1
  4. Paediatric visceral leishmaniasis: a retrospective study on clinical manifestations, demographic features and laboratory findings of hospitalised cases in Iran between 2006 and 2016 vol.49, pp.1, 2019, https://doi.org/10.1177/0049475518811513
  5. Seroepidemiological study on visceral leishmaniasis in an endemic focus of central Iran during 2017 vol.43, pp.1, 2019, https://doi.org/10.1007/s12639-018-1049-0
  6. Seroepidemiology of visceral leishmaniasis among free-roaming dogs and children in Zahedan city, southeast of Iran, 2018-2020 vol.161, pp.no.pa, 2021, https://doi.org/10.1016/j.micpath.2021.105234